23. Februar 2024 | 33:42 min.
Webinar Series
Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2
Early stage IP strategy pays off – Our experts Dr. Anja Lunze, LL.M. & Tobias Baus explained the pros and cons of IP protection, how to build a custom IP strategy with a matching IP portfolio, and why early patent protection is essential for biotech & pharma start-ups.
In dieser Serie
Coffee Break Life Sciences Start-ups | Overview page
Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1
30. January 2024
Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2
23. February 2024
Tips and tricks for your financing round | Coffee Break Life Sciences Start-ups #3
20. March 2024
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
18. April 2024
Employment Law in a Nutshell | Coffee Break Life Sciences Start-ups #5
15. May 2024
von Dr. Jan W. Grawe
Consulting Agreements: Dos and Don’ts | Coffee Break Life Sciences Start-ups #6
26. June 2024
Clinical trials in the pharmaceutical area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #7
18. July 2024
Clinical trials in the medical devices area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #8
22. August 2024
Data Protection for Life Sciences start-ups, particularly in connection with clinical trials | Coffee Break Life Sciences Start-ups #9
27. September 2024
Think big – possible exit strategies | Coffee Break Life Sciences Start-ups #10
20. October 2024
Website, Social Media, Advertising & Co. | Coffee Break Life Sciences Start-ups #11
19. November 2024
Would you like to receive future invitations to our webinar series?
Then sign up for our mailing list.Related Insights
Claiming the clock: Mastering patent limitation periods and their impact on contract design| Life Sciences Quarterly #2
von Dr. Anja Lunze, LL.M. und Dr. Aurel-Damian Roscher, LL.M.
Everything biologic and biosimilar in-house counsel need to know about COVID-19
von mehreren Autoren
The Bolar and related exemptions in Europe
What activity do they cover?
von mehreren Autoren